Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,152.93
+0.49000.04%
Post-market: 1,152.50-0.4300-0.04%16:08 EDT
Volume:4.22M
Turnover:4.86B
Market Cap:1.09T
PE:38.70
High:1,157.60
Open:1,150.00
Low:1,140.27
Close:1,152.44
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:2.29
T/O Rate:0.45%
Dividend:6.69
Dividend Rate:0.58%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.17
PE(LYR):50.24

Loading ...

PRESS Digest-financial Times - July 22

Reuters
·
Jul 22

Trump Announces Two-Year Zero Tariffs On Imported Generics From Aug. 1, 2026; Then 100% And 200% Hikes

MT Newswires Live
·
Jul 22

Sector Update: Healthcare

MT Newswires Live
·
Jul 22

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising

MT Newswires Live
·
Jul 21

Eli Lilly: Rather than Compete on the Merits of Its Products, Novo is Asking Court to Stop Lilly from Communicating Results of That Trial

THOMSON REUTERS
·
Jul 21

Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"

THOMSON REUTERS
·
Jul 21

Eli Lilly: We Will Continue to Focus on the Science and Defend Against Novo Nordisk Lawsuit Vigorously

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Lawsuit Over Weight-Loss Drug Ads! Accused By Novo Nordisk Of "Misleading Marketing"

Sector Pulse
·
Jul 21

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Reuters
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS
·
Jul 21

South Africa Regulator Reviews 12 Generic Semaglutide Applications

Reuters
·
Jul 21

Eli Lilly & Co. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO

MT Newswires Live
·
Jul 20